APT Medical Inc. (SHA:688617)
China · Delayed Price · Currency is CNY 286.87
+8.55 (3.07%)
Nov 13, 2026, 3:00 PM CST
APT Medical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,291 | 1,264 | 1,081 | 1,276 | 250.88 | 309.66 |
Trading Asset Securities | 497.76 | 250.49 | - | 60 | 881.34 | 913.72 |
Cash & Short-Term Investments | 1,789 | 1,515 | 1,081 | 1,336 | 1,132 | 1,223 |
Cash Growth | 30.08% | 40.13% | -19.10% | 18.03% | -7.45% | 916.56% |
Accounts Receivable | 68.17 | 78.22 | 83.29 | 41.78 | 47.15 | 34.01 |
Other Receivables | 3.67 | 14.81 | 20.45 | 8.76 | 14.14 | 13.45 |
Receivables | 71.85 | 93.03 | 103.74 | 50.54 | 61.29 | 47.46 |
Inventory | 512.33 | 491.96 | 399.32 | 327.95 | 337.94 | 263.25 |
Other Current Assets | 47.83 | 22.35 | 32.54 | 41.18 | 26.01 | 19.15 |
Total Current Assets | 2,421 | 2,122 | 1,617 | 1,756 | 1,557 | 1,553 |
Property, Plant & Equipment | 928.24 | 832.78 | 671.58 | 464.46 | 319.93 | 258.73 |
Long-Term Investments | 184.26 | 162.68 | 178.91 | 159.8 | 178.17 | 121.27 |
Goodwill | 48.13 | 48.13 | 48.13 | 48.13 | - | - |
Other Intangible Assets | 382.65 | 390.36 | 402 | 83 | 38.92 | 32.38 |
Long-Term Deferred Tax Assets | 35.4 | 39.79 | 27.44 | 10.73 | 12.64 | 9.82 |
Long-Term Deferred Charges | 1.67 | 2.7 | 3.4 | 5.95 | 5.09 | 7.41 |
Other Long-Term Assets | 19.68 | 53.17 | 32.55 | 44.83 | 113.77 | 30.24 |
Total Assets | 4,021 | 3,652 | 2,981 | 2,573 | 2,226 | 2,013 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 61.16 | 60.32 | 46.32 | 42.73 | 34.65 | 18 |
Accrued Expenses | 197.48 | 239.49 | 192.09 | 161.28 | 119.18 | 94.68 |
Short-Term Debt | - | - | - | 70 | 30 | 16 |
Current Portion of Long-Term Debt | 8.24 | 0.16 | 0.59 | 1.18 | 7.27 | 6.09 |
Current Portion of Leases | - | 7.67 | 5.83 | 10.1 | 6.26 | 7.46 |
Current Income Taxes Payable | 78.29 | 40.83 | 27.1 | 19.86 | 13.3 | 9.35 |
Current Unearned Revenue | 85.55 | 54.34 | 45.66 | 44.4 | 38.65 | 32.32 |
Other Current Liabilities | 110.96 | 56.15 | 88.39 | 238.62 | 162.57 | 10.63 |
Total Current Liabilities | 541.67 | 458.96 | 405.97 | 588.17 | 411.88 | 194.53 |
Long-Term Debt | - | 3.76 | - | 0.59 | 1.77 | 10.23 |
Long-Term Leases | 3.75 | 7.81 | 4.87 | 7.99 | 7.29 | 6.8 |
Long-Term Unearned Revenue | 58.54 | 47.55 | 11.26 | 8.74 | 7.06 | 7.3 |
Long-Term Deferred Tax Liabilities | 2.17 | 2.41 | 2.74 | 5.49 | 6.92 | 3.16 |
Other Long-Term Liabilities | - | 1.02 | 1.02 | - | - | - |
Total Liabilities | 606.13 | 521.51 | 425.85 | 610.98 | 434.91 | 222.02 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 141.53 | 141.03 | 97.39 | 66.86 | 66.67 | 66.67 |
Additional Paid-In Capital | 769.03 | 702.6 | 784.5 | 724.04 | 1,013 | 1,268 |
Retained Earnings | 3,024 | 2,344 | 1,685 | 1,141 | 716.83 | 425.49 |
Treasury Stock | -549.98 | -99.94 | -59.99 | -59.99 | -59.99 | - |
Comprehensive Income & Other | 0.13 | 1.35 | 9.6 | 34.96 | 27.22 | 17.89 |
Total Common Equity | 3,385 | 3,089 | 2,516 | 1,907 | 1,763 | 1,778 |
Minority Interest | 29.75 | 41.68 | 38.5 | 54.86 | 27.75 | 12.95 |
Shareholders' Equity | 3,415 | 3,130 | 2,555 | 1,962 | 1,791 | 1,791 |
Total Liabilities & Equity | 4,021 | 3,652 | 2,981 | 2,573 | 2,226 | 2,013 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 11.99 | 19.4 | 11.29 | 89.86 | 52.59 | 46.58 |
Net Cash (Debt) | 1,777 | 1,496 | 1,070 | 1,247 | 1,080 | 1,177 |
Net Cash Growth | 31.30% | 39.79% | -14.18% | 15.46% | -8.26% | 1348.33% |
Net Cash Per Share | 12.69 | 10.57 | 7.56 | 8.79 | 7.60 | 8.53 |
Filing Date Shares Outstanding | 139.23 | 140.63 | 140.57 | 139.92 | 139.52 | 140.17 |
Total Common Shares Outstanding | 139.23 | 140.63 | 140.57 | 139.92 | 140.17 | 140.17 |
Working Capital | 1,879 | 1,663 | 1,211 | 1,168 | 1,146 | 1,359 |
Book Value Per Share | 24.31 | 21.96 | 17.90 | 13.63 | 12.58 | 12.69 |
Tangible Book Value | 2,954 | 2,650 | 2,066 | 1,776 | 1,724 | 1,746 |
Tangible Book Value Per Share | 21.22 | 18.85 | 14.70 | 12.69 | 12.30 | 12.45 |
Buildings | - | 289.62 | 262.05 | 173.2 | 150.44 | 81.94 |
Machinery | - | 710.02 | 590.75 | 402.93 | 277.15 | 223.7 |
Construction In Progress | - | 137.85 | 46.34 | 47.84 | 14.99 | 37.31 |